CHANDLER, Ariz.--(BUSINESS WIRE)--InNexus Biotechnology Inc. (TSX:IXS.V), a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announced today that the company along with local Arizona partners, has received a joint research program award sponsored by the Arizona Biomedical Research Commission.
